Scientific Literature Database Coverage of Randomized Clinical Trials for Central Serous Chorioretinopathy.
biomedical literature database
central serous chorioretinopathy
evidence synthesis methodology
indexing
randomized clinical trials
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
12 Jun 2023
12 Jun 2023
Historique:
received:
05
05
2023
revised:
05
06
2023
accepted:
09
06
2023
medline:
28
6
2023
pubmed:
28
6
2023
entrez:
28
6
2023
Statut:
epublish
Résumé
Systematic literature searches are the cornerstone of systematic reviews. In this study, we evaluated database coverage of randomized clinical trials for central serous chorioretinopathy (CSC). We searched 12 databases (BIOSIS Previews, CINAHL, the Cochrane Central, Current Contents Connect, Data Citation Index, Derwent Innovations Index, EMBASE, KCI-Korean Journal Database, MEDLINE, PubMed, SciELO Citation Index, and Web of Science Core Collection) on 10 April 2023 for randomized clinical trials for CSC. After identifying all eligible studies across all databases, we investigated the coverage of these studies within each database, including the coverage of any combination of two databases. The 12 databases yielded 848 records for screening, of which 76 were randomized clinical trials for CSC. No single database provided full coverage. The most comprehensive coverage was provided by EMBASE (88%), the Cochrane Central (87%), and PubMed (75%). A combined search in the Cochrane Central and PubMed led to complete coverage (100%) while reducing the number of records for screening from 848 to 279. Systematic review search design should include multiple databases. For randomized clinical trials for CSC, the combination of the Cochrane Central and PubMed provides an excellent balance between coverage and workload.
Sections du résumé
BACKGROUND
BACKGROUND
Systematic literature searches are the cornerstone of systematic reviews. In this study, we evaluated database coverage of randomized clinical trials for central serous chorioretinopathy (CSC).
METHODS
METHODS
We searched 12 databases (BIOSIS Previews, CINAHL, the Cochrane Central, Current Contents Connect, Data Citation Index, Derwent Innovations Index, EMBASE, KCI-Korean Journal Database, MEDLINE, PubMed, SciELO Citation Index, and Web of Science Core Collection) on 10 April 2023 for randomized clinical trials for CSC. After identifying all eligible studies across all databases, we investigated the coverage of these studies within each database, including the coverage of any combination of two databases.
RESULTS
RESULTS
The 12 databases yielded 848 records for screening, of which 76 were randomized clinical trials for CSC. No single database provided full coverage. The most comprehensive coverage was provided by EMBASE (88%), the Cochrane Central (87%), and PubMed (75%). A combined search in the Cochrane Central and PubMed led to complete coverage (100%) while reducing the number of records for screening from 848 to 279.
CONCLUSIONS
CONCLUSIONS
Systematic review search design should include multiple databases. For randomized clinical trials for CSC, the combination of the Cochrane Central and PubMed provides an excellent balance between coverage and workload.
Identifiants
pubmed: 37373972
pii: jpm13060983
doi: 10.3390/jpm13060983
pmc: PMC10305376
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Arthritis. 2012;2012:624830
pubmed: 22924128
Acta Ophthalmol. 2022 Feb;100(1):89-95
pubmed: 33998168
Graefes Arch Clin Exp Ophthalmol. 2023 Mar;261(3):659-668
pubmed: 36202933
JAMA Ophthalmol. 2023 Apr 1;141(4):315-323
pubmed: 36795396
J Clin Med. 2022 Jul 29;11(15):
pubmed: 35956052
Syst Rev. 2016 Feb 09;5:27
pubmed: 26862061
Acta Ophthalmol. 2022 Nov;100(7):e1522-e1532
pubmed: 35388619
Health Libr Rev. 1999 Sep;16(3):151-6
pubmed: 10620849
Health Technol Assess. 2003;7(34):iii, ix-x, 1-51
pubmed: 14609481
Br J Ophthalmol. 2022 Dec;106(12):1748-1753
pubmed: 34261662
Eye (Lond). 2019 Jan;33(1):14-33
pubmed: 29995841
Ophthalmol Ther. 2020 Jun;9(2):329-342
pubmed: 32279234
Clin Ophthalmol. 2016 Dec 20;11:39-46
pubmed: 28053499
Res Synth Methods. 2022 Nov;13(6):760-789
pubmed: 35657294
Ophthalmol Ther. 2022 Dec;11(6):2225-2242
pubmed: 36198880
Ophthalmol Ther. 2023 Apr;12(2):1073-1080
pubmed: 36692812
Acta Ophthalmol. 2023 Mar;101(2):140-159
pubmed: 36178171
Syst Rev. 2017 Aug 8;6(1):156
pubmed: 28789703
Prog Retin Eye Res. 2019 Nov;73:100770
pubmed: 31319157
J Clin Med. 2022 Aug 16;11(16):
pubmed: 36013005
Am J Ophthalmol. 2002 Jun;133(6):787-93
pubmed: 12036670
Retina. 2023 Mar 1;43(3):379-388
pubmed: 36727801
Acta Ophthalmol. 2022 Dec;100(8):946-959
pubmed: 35179828
BMC Med Res Methodol. 2021 Apr 30;21(1):94
pubmed: 33941105